Zobrazeno 1 - 10
of 227
pro vyhledávání: '"Stéphane Leprêtre"'
Autor:
David Morland, Lukshe Kanagaratnam, Fabrice Hubelé, Elise Toussaint, Sylvain Choquet, Aurélie Kas, Pierre-Ambroise Caquot, Corinne Haioun, Emmanuel Itti, Stéphane Leprêtre, Pierre Decazes, Fontanet Bijou, Paul Schwartz, Caroline Jacquet, Adrien Chauchet, Julien Matuszak, Nassim Kamar, Pierre Payoux, K-VIROGREF Study Group, Eric Durot
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Background Besides International Prognostic Index (IPI) score, baseline prognostic factors of post-transplant lymphoproliferative disorders (PTLD) are poorly identified due to the rarity of the disease. New indexes derived from healthy organ
Externí odkaz:
https://doaj.org/article/938661d0b675480cade62b8d05c6d279
Autor:
Vincent Camus, Pascaline Etancelin, Fanny Drieux, Elena‐Liana Veresezan, Jean‐Michel Picquenot, Dominique Penther, Mathieu Viennot, Philippe Ruminy, Nathalie Contentin, Emilie Lemasle, Stéphane Leprêtre, Sydney Dubois, Juliette Penichoux, Aspasia Stamatoullas, Alexandra Zduniak, Hélène Lanic, Fabrice Jardin
Publikováno v:
Clinical Case Reports, Vol 11, Iss 6, Pp n/a-n/a (2023)
Key Clinical Message This case report highlights the potential of belinostat for the treatment of relapsed/refractory peripheral T‐cell lymphomas, for which effective therapies are still scarce. Abstract Peripheral T‐cell lymphomas have an aggres
Externí odkaz:
https://doaj.org/article/d1d685bef59a487b9e63e1b0375ee0d9
Autor:
David Morland, Lukshe Kanagaratnam, Fabrice Hubelé, Elise Toussaint, Sylvain Choquet, Aurélie Kas, Pierre-Ambroise Caquot, Corinne Haioun, Emmanuel Itti, Stéphane Leprêtre, Pierre Decazes, Fontanet Bijou, Paul Schwartz, Caroline Jacquet, Adrien Chauchet, Julien Matuszak, Nassim Kamar, Pierre Payoux, K-VIROGREF Study Group, Eric Durot
Publikováno v:
HemaSphere, Vol 7, Iss 2, p e833 (2023)
Post-transplant lymphoproliferative disorder (PTLD) is a rare complication of immunosuppression. Sequential treatment is commonly proposed, combining induction with rituximab (R-induction) followed by either continuation of treatment or addition of c
Externí odkaz:
https://doaj.org/article/543a51ba0dfe4d3f998930f3e323fe57
Autor:
Isabelle Duroux-Richard, Anne-Laure Gagez, Elina Alaterre, Rémi Letestu, Olfa Khalifa, Christian Jorgensen, Stéphane Leprêtre, Emmanuelle Tchernonog, Jérôme Moreaux, Guillaume Cartron, Florence Apparailly
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
During many years, chemo-immunotherapy fludarabine-cyclophosphamide-rituximab (FCR) was the gold standard for first line treatment of medically fit patients with symptomatic B-chronic lymphocytic leukemia (CLL). Over the last decade, targeted biother
Externí odkaz:
https://doaj.org/article/1ff8fb046b8b456b860dc1a536915379
Autor:
Juliette Pénichoux, Florian Bouclet, Mustafa Alani, Nathalie Contentin, Anne‐Lise Ménard, Stéphane Leprêtre, Pascal Lenain, Aspasia Stamatoullas, Elodie Lhuillier, Hélène Lanic, Emilie Lemasle, Sydney Dubois, Jean‐Henri Bourhis, Hervé Mal, Fabrice Jardin, Vincent Camus
Publikováno v:
Clinical Case Reports, Vol 10, Iss 9, Pp n/a-n/a (2022)
Abstract Allogeneic stem cell transplant and chronic graft‐versus‐host disease may lead to severe non‐infectious pulmonary disease in 6% of patients at 5 years. We report the case of a young patient with acute myeloid leukemia who successfully
Externí odkaz:
https://doaj.org/article/e738896d47fc404796ecabd8a48667b1
Autor:
Kamel Laribi, Alix Baugier de Materre, David Ghez, Caroline Dartigeas, Cécile Tomowiak, Béatrice Mahé, Jean-Baptiste Micol, Fatiha Merabet, Stéphane Leprêtre, Charles Herbaux, Loïc Ysebaert, Ronan Le Calloch, Lise Willems, Maud Voldoire, Damien Roos-Weil, Clotilde Bravetti, Yamina Touileb, Frédéric Davi, Florence Nguyen-Khac, Karim Maloum, Marie C. Béné
Publikováno v:
HemaSphere, Vol 6, Iss 6, p e716 (2022)
Externí odkaz:
https://doaj.org/article/1e24f9087c84404881a2b66fd7aa9531
Autor:
Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, Efstathios Kastritis, Shirley D’Sa, Ramon Garcia-Sanz, Cécile Tomowiak, Bénédicte Hivert, Elise Toussaint, Caroline Protin, Jithma P. Abeykoon, Thomas Guerrero-Garcia, Gilad Itchaki, Josephine M. Vos, Anne-Sophie Michallet, Sophie Godet, Jehan Dupuis, Stéphane Leprêtre, Joshua Bomsztyk, Pierre Morel, Véronique Leblond, Steven P. Treon, Meletios A. Dimopoulos, Prashant Kapoor, Alain Delmer, Jorge J. Castillo
Publikováno v:
Haematologica, Vol 106, Iss 11 (2020)
Histological transformation into diffuse large B-cell lymphoma is a rare complication in patients with Waldenström macroglobulinemia (WM) and is usually associated with a poor prognosis. The objective of this study was to develop and validate a prog
Externí odkaz:
https://doaj.org/article/0931a2c3a1de4a5db0e8afca81e892d7
Autor:
Anne Quinquenel, Thérèse Aurran-Schleinitz, Aline Clavert, Florence Cymbalista, Caroline Dartigeas, Frédéric Davi, Sophie de Guibert, Alain Delmer, Marie-Sarah Dilhuydy, Pierre Feugier, Luc-Matthieu Fornecker, David Ghez, Romain Guieze, Kamel Laribi, Véronique Leblond, Stéphane Leprêtre, Rémi Letestu, Vincent Lévy, Florence Nguyen-Khac, Anne-Sophie Michallet, Cécile Tomowiak, Olivier Tournilhac, Loïc Ysebaert, Xavier Troussard, on the behalf of the FILO-LLC Group
Publikováno v:
HemaSphere, Vol 4, Iss 5, p e473 (2020)
Abstract. As a result of significant recent developments, the management of patients with chronic lymphocytic leukemia (CLL) is changing, and new therapeutic options will continue to emerge in the near future. The recommendations of the French Innova
Externí odkaz:
https://doaj.org/article/09eb754c87c6431b99b76fa1236289e3
Autor:
Jonathan Bond, Aurore Touzart, Stéphane Leprêtre, Carlos Graux, Mario Bargetzi, Ludovic Lhermitte, Guillaume Hypolite, Thibaut Leguay, Yosr Hicheri, Gaëlle Guillerm, Karin Bilger, Véronique Lhéritier, Mathilde Hunault, Françoise Huguet, Yves Chalandon, Norbert Ifrah, Elizabeth Macintyre, Hervé Dombret, Vahid Asnafi, Nicolas Boissel
Publikováno v:
Haematologica, Vol 104, Iss 8 (2019)
The prognostic implications of DNMT3A genotype in T-cell acute lymphoblastic leukemia are incompletely understood. We performed comprehensive genetic and clinico-biological analyses of T-cell acute lymphoblastic leukemia patients with DNMT3A mutation
Externí odkaz:
https://doaj.org/article/c7874af4303e437f94ab5be0fb3f19e0
Autor:
Guillaume Cartron, Rémi Letestu, Caroline Dartigeas, Mira Tout, Béatrice Mahé, Anne-Laure Gagez, Emmanuelle Ferrant, Boris Guiu, Bruno Villemagne, Phan Letuan, Thérèse Aurran, Frédérique Orsini-Piocelle, Anne Banos, Pierre Feugier, Véronique Leblond, Sophie de Guibert, Olivier Tournilhac, Jehan Dupuis, Alain Delmer, Valérie Rouillé, David Ternant, Stéphane Leprêtre
Publikováno v:
Haematologica, Vol 103, Iss 8 (2018)
Externí odkaz:
https://doaj.org/article/3efef2e93dba41048896b6b9d7ffdb2e